Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.
about
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinomaChemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinomaEmerging treatment options for nasopharyngeal carcinomaRole of chemotherapy in nasopharyngeal carcinomaParotid area lymph node metastases from preliminarily diagnosed patients with nasopharyngeal carcinoma: report on tumor characteristics and oncologic outcomesWhat Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.The role of concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma.Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinomaSignificant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials.Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial.Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter studySafety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.The Effect of Adding Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Undetectable Pretreatment Epstein-Barr Virus DNA.The efficacy and toxicities of intensive induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with N3 disease.Chemoradiotherapy enhanced the efficacy of radiotherapy in nasopharyngeal carcinoma patients: a network meta-analysisAdding maximum standard uptake value of primary lesion and lymph nodes in 18F-fluorodeoxyglucose PET helps predict distant metastasis in patients with nasopharyngeal carcinoma.Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma.Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-upStat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinomaEffectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study.Phase II trial of concurrent chemoradiotherapy with S-1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma.Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy.Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone.Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials.The long-term outcomes of alternating chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multiinstitutional phase II studyPretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma.Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.Neoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated RadiotherapySurrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis.Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis.Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy.
P2860
Q24200903-081E445A-C873-4B33-8BC1-0D231EFEC1E7Q24243898-A3273009-91B1-44B3-AFBE-A88232585B5FQ26995560-4AEAD212-F0E6-4FF1-AA63-931FAA05D941Q27022454-090B0262-B09A-4132-8B61-6F939B3BAECCQ30375441-9A292B8E-23CE-4351-9533-CCEEF7FD3DA0Q31146986-7AB622DD-15C0-48E2-90DA-4E2A2798DC63Q33420052-41D05029-5035-403E-B995-847D7A5C33AEQ33425830-47A9E95D-2841-47CB-926F-53F84C5FAEEEQ33428012-114E7B2F-35CA-4AB6-BC0F-A99DF4741355Q33428455-3B97E7F1-CC40-4F33-B2EC-EB516F7E0696Q33433507-70D7B371-B52E-4EB1-9B21-5FCFC4E2F279Q33435906-90903DE9-ACFE-4135-8687-06DACE24794CQ33436774-83B4EE7E-A2A8-4E02-B1E4-03E2EB8DB56FQ33439337-A812C9A2-A27E-4C4C-A46F-7DA3CB8F7226Q33441222-ED978EAD-F47C-4D42-B749-1206D6ED079EQ33442582-E9C3D863-BCAE-4513-8880-CE04E1D30458Q33602326-ABD244B9-5671-4709-BA7B-41F53A8998FDQ33752579-4E23291F-7180-430C-BA7B-29ACA7FD32C9Q33808152-59C542EC-7264-4DCB-82EC-9C667CAE833AQ33889391-A20F57B4-66DE-4EA0-9E90-F57846E13C3FQ33961339-974F3566-923A-446A-9E99-74D89A7D4C1AQ34367552-EF64C168-463D-4EFE-A5EC-12C598223BDCQ34492567-FB85358A-A8D2-43F2-990E-EE7C39F097D2Q34575479-F5E68127-9300-451C-BA91-F874BEAD2A36Q35114677-617F3562-08F9-4DC6-B0CE-5814932A9FA0Q35534813-9524CCCD-7E82-49AB-8F40-6225EA8D988BQ35717112-23AF7AB6-65FE-4017-9279-3E1F9BB2E2D1Q35753624-CD66D1C0-DDC2-420C-8DF8-0D10CC93BA2BQ35823316-E15E2838-BAC1-4D83-96E0-D2F89A7535F2Q35824278-069E26F2-1804-495A-97CC-4BCD2F4340BDQ35851730-AE7A6246-22B3-4859-A5B7-7789B169916CQ35908143-EFD1DF13-7771-455B-B4D8-CCDC103AB992Q35942191-ECCD25C0-F5D9-49BE-A9DE-C79FCA68D580Q36023869-869F5AA4-0499-44DE-8CEA-C660E677F77FQ36043428-4A28B5F5-80A8-4B18-85B0-EFA3DE322574Q36100299-872F9D06-204C-4C50-8675-B4384591DC72Q36174879-0C0BB0F2-C658-4220-9D48-1B191179D2B1Q36215439-4D1B57FA-D030-4C97-9415-2CFE15EE06FAQ36267133-48CD214C-48C3-4B73-A146-E884FEC53278Q36275495-5C774213-BFAD-4D2E-95F2-AD0F3F56CEC7
P2860
Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Randomized phase II trial of c ...... nced nasopharyngeal carcinoma.
@en
type
label
Randomized phase II trial of c ...... nced nasopharyngeal carcinoma.
@en
prefLabel
Randomized phase II trial of c ...... nced nasopharyngeal carcinoma.
@en
P2093
P50
P356
P1476
Randomized phase II trial of c ...... nced nasopharyngeal carcinoma.
@en
P2093
Ann D King
Brian K Yu
Edwin P Hui
Frankie Mo
Michael K Kam
Rosalie Ho
Samuel K Chiu
Sing F Leung
Wing H Kwan
P304
P356
10.1200/JCO.2008.18.1545
P407
P577
2008-12-08T00:00:00Z